Showing results (181-190 of 395) with videos related to
Sort By:
Pageof 40
Leukemia|August 29, 2019
Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN studyFrancesc Bosch, Guy Cantin, Agostino Cortelezzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter's syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow TransplantationKate Cwynarski, Anja van Biezen, Liesbeth de Wreede, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2022
Circulating Tumor DNA-Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and VenetoclaxMoritz Fürstenau, Jonathan Weiss, Adam Giza, et al.Cancer Immunology, Immunotherapy : CII|April 18, 2020
Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potentialMoritz Bewarder, Gerhard Held, Lorenz Thurner, et al.British Journal of Haematology|August 16, 2005
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II studyMark Ringhoffer, Norbert Blumstein, Bernd Neumaier, et al.Genome Research|September 12, 2023
Nucleosome repositioning in chronic lymphocytic leukemiaKristan V Piroeva, Charlotte McDonald, Charalampos Xanthopoulos, et al.Intensive Care Medicine Experimental|September 3, 2021
Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019Vadim Lesan, Moritz Bewarder, Carlos Metz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factorsDirk Kienle, Tiemo Katzenberger, German Ott, et al.Cancer Research|November 17, 2006
Molecular imaging of proliferation in malignant lymphomaAndreas K Buck, Martin Bommer, Stephan Stilgenbauer, et al.European Journal of Haematology|November 19, 2016
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trialOthman Al-Sawaf, Kirsten Fischer, Carmen D Herling, et al.Pageof 40